11904 results
Keyword Pregabalin Accord Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Teriflunomide Accord
Teriflunomide, Multiple Sclerosis, Relapsing-Remitting
Date of authorisation: 09/11/2022,
, Authorised, Last updated: 14/11/2022
Teriflunomide Accord Multiple Sclerosis Demyelinating … Teriflunomide Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Imatinib Accord
imatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma; Dermatofibrosarcoma; Myelodysplastic-Myeloproliferative Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hypereosinophilic Syndrome
Date of authorisation: 30/06/2013,, Revision: 20, Authorised, Last updated: 14/12/2022
Imatinib Accord Neoplasms Cancer Leukemia … Imatinib Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Aripiprazole Accord
aripiprazole, Schizophrenia; Bipolar Disorder
Date of authorisation: 15/11/2015,, Revision: 15, Authorised, Last updated: 13/07/2022
Aripiprazole Accord Schizophrenia Spectrum and … Aripiprazole Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Tigecycline Accord
Tigecycline, Soft Tissue Infections; Intraabdominal Infections; Bacterial Infections; Skin Diseases, Infectious
Date of authorisation: 17/04/2020,, Revision: 4, Authorised, Last updated: 29/07/2022
Tigecycline Accord Infections Bacterial Infections … Tigecycline Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Entecavir Accord
Entecavir, Hepatitis B, Chronic
Date of authorisation: 25/09/2017,, Revision: 5, Authorised, Last updated: 29/07/2022
Entecavir Accord Infections Communicable … Entecavir Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Voriconazole Accord
voriconazole, Aspergillosis; Candidiasis; Mycoses
Date of authorisation: 16/05/2013,, Revision: 16, Authorised, Last updated: 25/04/2022
Voriconazole Accord Infections Bacterial Infections … Voriconazole Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Temozolomide Accord
temozolomide, Glioma; Glioblastoma
Date of authorisation: 15/03/2010,, Revision: 22, Authorised, Last updated: 21/03/2022
Temozolomide Accord Cancer Neuroectodermal … Temozolomide Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Apixaban Accord
Apixaban, Venous Thromboembolism; Stroke; Arthroplasty
Date of authorisation: 23/07/2020,, Revision: 2, Authorised, Last updated: 19/05/2022
Apixaban Accord Thromboembolism Embolism … Apixaban Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Fampridine Accord
Fampridine, Multiple Sclerosis
Date of authorisation: 24/09/2020,, Revision: 1, Authorised, Last updated: 10/05/2022
Fampridine Accord Nervous System Diseases Autoimmune … Fampridine Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Repaglinide Accord
repaglinide, Diabetes Mellitus, Type 2
Date of authorisation: 22/12/2011,, Revision: 7, Authorised, Last updated: 21/01/2022
Repaglinide Accord Nutritional and Metabolic … Repaglinide Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Palonosetron Accord
Palonosetron, Vomiting; Nausea; Cancer
Date of authorisation: 26/05/2016,, Revision: 5, Authorised, Last updated: 13/01/2022
Palonosetron Accord Pathological Conditions … Palonosetron Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Lenalidomide Accord
lenalidomide, Multiple Myeloma
Date of authorisation: 20/09/2018,, Revision: 9, Authorised, Last updated: 31/03/2022
Lenalidomide Accord Cancer Neoplasms Neoplasms … Lenalidomide Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Bortezomib Accord
bortezomib, Multiple Myeloma
Date of authorisation: 20/07/2015,, Revision: 13, Authorised, Last updated: 25/03/2022
Bortezomib Accord Hemostatic Disorders Vascular … Bortezomib Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Rivaroxaban Accord
rivaroxaban, Acute Coronary Syndrome; Coronary Artery Disease; Peripheral Arterial Disease; Venous Thromboembolism; Stroke; Atrial Fibrillation; Pulmonary Embolism
Date of authorisation: 16/11/2020,, Revision: 2, Authorised, Last updated: 28/03/2022
Rivaroxaban Accord Cardiovascular Diseases Vascular … Rivaroxaban Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Capecitabine Accord
capecitabine, Colonic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Stomach Neoplasms
Date of authorisation: 20/04/2012,, Revision: 16, Authorised, Last updated: 10/12/2021
Capecitabine Accord Cancer Neoplasms Colorectal … Capecitabine Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Sunitinib Accord
sunitinib, Gastrointestinal Stromal Tumors; Carcinoma, Renal Cell; Neuroendocrine Tumors
Date of authorisation: 11/02/2021,
, , Revision: 1, Authorised, Last updated: 14/12/2021
Sunitinib Accord Cancer Neoplasms Neoplasms … Sunitinib Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Cinacalcet Accordpharma (updated)
cinacalcet hydrochloride, Hyperparathyroidism
Date of authorisation: 03/04/2020,, Revision: 3, Authorised, Last updated: 16/05/2023
Cinacalcet Accordpharma Endocrine System Diseases Parathyroid … cinacalcet Overview Cinacalcet Accordpharma is a medicine used to treat … no other cause. Cinacalcet Accordpharma contains the The substance … -
List item
Human medicine European public assessment report (EPAR): Plerixafor Accord
Plerixafor, Multiple Myeloma; Hematopoietic Stem Cell Transplantation
Date of authorisation: 16/12/2022,, , Authorised, Last updated: 06/02/2023
Plerixafor Accord Lymphoproliferative Disorders Lymphatic … plerixafor Overview Plerixafor Accord is a medicine used to mobilise … same patient. Plerixafor Accord is used together with the … -
List item
Human medicine European public assessment report (EPAR): Fingolimod Accord (updated)
fingolimod hydrochloride , Multiple Sclerosis, Relapsing-Remitting
Date of authorisation: 25/06/2020,, Revision: 3, Authorised, Last updated: 17/05/2023
Fingolimod Accord Nervous System Diseases Autoimmune … fingolimod Overview Fingolimod Accord is a type of medicine known … remissions). Fingolimod Accord is used when the disease … -
List item
Human medicine European public assessment report (EPAR): Dasatinib Accord
dasatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Date of authorisation: 24/03/2022,, Revision: 1, Withdrawn, Last updated: 30/03/2023
Dasatinib Accord Leukemia, Lymphoid Leukemia Neoplasms Lymphoproliferative … Dasatinib Accord … Public statement Dasatinib Accord (dasatinib) Withdrawal of … -
List item
Human medicine European public assessment report (EPAR): Dasatinib Accordpharma
dasatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Date of authorisation: 24/03/2022,, Revision: 1, Withdrawn, Last updated: 30/03/2023
Dasatinib Accordpharma Leukemia, Lymphoid Leukemia Neoplasms Lymphoproliferative … Dasatinib Accordpharma … Public statement Dasatinib Accordpharma (dasatinib) Withdrawal of … -
List item
Human medicine European public assessment report (EPAR): Sorafenib Accord
Sorafenib tosilate, Carcinoma, Hepatocellular; Carcinoma, Renal Cell
Date of authorisation: 09/11/2022,, Authorised, Last updated: 25/11/2022
Sorafenib Accord Adenocarcinoma Neoplasms … Sorafenib Accord … EMEA/H/C/005921 Sorafenib Accord (sorafenib) An overview … -
List item
Human medicine European public assessment report (EPAR): Sitagliptin Accord
sitagliptin hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 25/04/2022,, Authorised, Last updated: 21/07/2022
Sitagliptin Accord Diabetes Mellitus Glucose … Sitagliptin Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Ivabradine Accord
ivabradine hydrochloride, Angina Pectoris; Heart Failure
Date of authorisation: 22/05/2017,, Revision: 6, Authorised, Last updated: 01/03/2022
Ivabradine Accord Pathological Conditions … Ivabradine Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Memantine Accord
memantine hydrochloride, Alzheimer Disease
Date of authorisation: 03/12/2013,, Revision: 7, Authorised, Last updated: 13/01/2022
Memantine Accord Nervous System Diseases Central … Memantine Accord … medicines are manufactured according to the same quality standards …